Loomis Sayles & Co. L P Has $74,000 Position in Aflac Incorporated (NYSE:AFL)

Loomis Sayles & Co. L P cut its position in shares of Aflac Incorporated (NYSE:AFL) by 17.2% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 716 shares of the financial services provider’s stock after selling 149 shares during the quarter. Loomis Sayles & Co. L P’s holdings in Aflac were worth $74,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Private Trust Co. NA grew its stake in shares of Aflac by 1.3% during the 4th quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider’s stock worth $791,000 after acquiring an additional 99 shares in the last quarter. Phillips Wealth Planners LLC boosted its holdings in Aflac by 1.5% during the fourth quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider’s stock worth $662,000 after purchasing an additional 100 shares during the last quarter. Raleigh Capital Management Inc. grew its position in Aflac by 23.2% in the fourth quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider’s stock valued at $55,000 after purchasing an additional 100 shares in the last quarter. TKG Advisors LLC increased its stake in Aflac by 0.5% in the 4th quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider’s stock valued at $2,230,000 after buying an additional 103 shares during the last quarter. Finally, Robertson Stephens Wealth Management LLC lifted its position in Aflac by 1.6% during the 4th quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider’s stock worth $720,000 after buying an additional 107 shares in the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Insider Transactions at Aflac

In other Aflac news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the transaction, the director now owns 25,393 shares in the company, valued at $2,733,048.59. This represents a 3.79 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the sale, the director now owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

Aflac Stock Down 1.0 %

Shares of AFL opened at $109.71 on Monday. The firm has a market cap of $59.88 billion, a P/E ratio of 11.43, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. Aflac Incorporated has a 52 week low of $79.31 and a 52 week high of $115.50. The firm’s 50-day simple moving average is $106.49 and its 200 day simple moving average is $107.66.

Aflac (NYSE:AFL) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, analysts forecast that Aflac Incorporated will post 6.88 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on AFL shares. Piper Sandler lowered their target price on Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. Morgan Stanley boosted their price target on Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. Evercore ISI cut their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a report on Wednesday, December 4th. Wells Fargo & Company decreased their target price on shares of Aflac from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Wednesday, February 19th. Finally, Barclays dropped their price target on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research report on Friday, February 7th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $103.36.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.